USD 3.63
(-6.2%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 460.02 Million USD | 2.37% |
2022 | 449.35 Million USD | 1.38% |
2021 | 443.25 Million USD | 50.52% |
2020 | 294.49 Million USD | 33.44% |
2019 | 220.68 Million USD | 34.83% |
2018 | 163.67 Million USD | -47.67% |
2017 | 312.79 Million USD | 0.44% |
2016 | 311.43 Million USD | 74715.66% |
2015 | 416.27 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 443.16 Million USD | -3.34% |
2024 Q1 | 458.48 Million USD | -0.34% |
2023 Q4 | 460.02 Million USD | -0.57% |
2023 Q3 | 462.64 Million USD | 2.74% |
2023 FY | 460.02 Million USD | 2.37% |
2023 Q2 | 450.31 Million USD | 0.94% |
2023 Q1 | 446.1 Million USD | -0.72% |
2022 FY | 449.35 Million USD | 1.38% |
2022 Q4 | 449.35 Million USD | -1.73% |
2022 Q2 | 456.35 Million USD | 4.6% |
2022 Q3 | 457.27 Million USD | 0.2% |
2022 Q1 | 436.27 Million USD | -1.58% |
2021 Q4 | 443.25 Million USD | 19.66% |
2021 FY | 443.25 Million USD | 50.52% |
2021 Q1 | 319.18 Million USD | 8.38% |
2021 Q2 | 355.56 Million USD | 11.4% |
2021 Q3 | 370.42 Million USD | 4.18% |
2020 Q3 | 246.42 Million USD | 13.83% |
2020 FY | 294.49 Million USD | 33.44% |
2020 Q4 | 294.49 Million USD | 19.51% |
2020 Q2 | 216.48 Million USD | 3.91% |
2020 Q1 | 208.34 Million USD | -5.59% |
2019 FY | 220.68 Million USD | 34.83% |
2019 Q4 | 220.68 Million USD | 26.37% |
2019 Q3 | 174.64 Million USD | 3.91% |
2019 Q2 | 168.07 Million USD | -4.75% |
2019 Q1 | 176.45 Million USD | 7.8% |
2018 FY | 163.67 Million USD | -47.67% |
2018 Q3 | 316.3 Million USD | 0.42% |
2018 Q4 | 163.67 Million USD | -48.25% |
2018 Q2 | 314.98 Million USD | 0.38% |
2018 Q1 | 313.79 Million USD | 0.32% |
2017 Q1 | 311.23 Million USD | -0.06% |
2017 Q2 | 311.56 Million USD | 0.1% |
2017 Q3 | 312.05 Million USD | 0.16% |
2017 Q4 | 312.79 Million USD | 0.24% |
2017 FY | 312.79 Million USD | 0.44% |
2016 Q4 | 311.43 Million USD | 3.21% |
2016 FY | 311.43 Million USD | 74715.66% |
2016 Q2 | 593.5 Thousand USD | 0.0% |
2016 Q3 | 301.74 Million USD | 50741.26% |
2015 FY | 416.27 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Cosmos Health Inc. | 66.29 Million USD | -593.9% |
Safety Shot Inc | 12.7 Million USD | -3519.628% |
Bright Green Corporation | 17.4 Million USD | -2543.359% |
Embecta Corp. | 1.21 Billion USD | 62.119% |
ANI Pharmaceuticals, Inc. | 904.42 Million USD | 49.136% |
Aquestive Therapeutics, Inc. | 57.41 Million USD | -701.186% |
Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 59.764% |
Dynavax Technologies Corporation | 997.09 Million USD | 53.864% |
Esperion Therapeutics, Inc. | 205.79 Million USD | -123.534% |
Intra-Cellular Therapies, Inc. | 728.29 Million USD | 36.835% |
Pacira BioSciences, Inc. | 1.57 Billion USD | 70.781% |
PainReform Ltd. | 9.93 Million USD | -4532.679% |
Sunshine Biopharma, Inc. | 27.34 Million USD | -1582.18% |
Sunshine Biopharma, Inc. | 27.34 Million USD | -1582.18% |
SCYNEXIS, Inc. | 128.41 Million USD | -258.241% |
China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -1889.12% |
Journey Medical Corporation | 76.84 Million USD | -498.609% |
Alpha Teknova, Inc. | 128.58 Million USD | -257.754% |
Procaps Group, S.A. | 460.18 Million USD | 0.035% |
Theratechnologies Inc. | 77.76 Million USD | -491.527% |
Harrow Health, Inc. | 311.75 Million USD | -47.56% |
Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -2988.867% |
Biofrontera Inc. | 27.93 Million USD | -1546.946% |
DURECT Corporation | 45.18 Million USD | -918.002% |
Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 67.35% |
Cronos Group Inc. | 1.13 Billion USD | 59.442% |
OptiNose, Inc. | 107.72 Million USD | -327.021% |
Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 2.345% |
Kala Pharmaceuticals, Inc. | 55.94 Million USD | -722.222% |
RedHill Biopharma Ltd. | 23.04 Million USD | -1896.018% |
Guardion Health Sciences, Inc. | 11.91 Million USD | -3759.86% |
Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -462.542% |
Radius Health, Inc. | 1.71 Billion USD | 73.191% |
Universe Pharmaceuticals INC | 53.28 Million USD | -763.296% |
ProPhase Labs, Inc. | 91.92 Million USD | -400.424% |
Phibro Animal Health Corporation | 982.18 Million USD | 53.163% |
Procaps Group S.A. | 460.18 Million USD | 0.035% |
Alvotech | 950.09 Million USD | 51.581% |
TherapeuticsMD, Inc. | 43.3 Million USD | -962.193% |
Viatris Inc. | 47.68 Billion USD | 99.035% |
Rockwell Medical, Inc. | 52.17 Million USD | -781.73% |
Aytu BioPharma, Inc. | 118.09 Million USD | -289.538% |
SIGA Technologies, Inc. | 254.83 Million USD | -80.518% |
Tilray Brands, Inc. | 4.33 Billion USD | 89.389% |
Lifecore Biomedical, Inc. | 273.7 Million USD | -68.075% |
Shineco, Inc. | 84.17 Million USD | -446.482% |
PetIQ, Inc. | 868.22 Million USD | 47.016% |
Regencell Bioscience Holdings Limited | 8.43 Million USD | -5351.689% |
Incannex Healthcare Limited | 17.04 Million USD | -2598.569% |
Neurocrine Biosciences, Inc. | 3.25 Billion USD | 85.851% |
Alimera Sciences, Inc. | 153.52 Million USD | -199.644% |
Silver Spike Investment Corp. | 88.57 Million USD | -419.355% |
Assertio Holdings, Inc. | 286.41 Million USD | -60.613% |
Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -7629.257% |
Petros Pharmaceuticals, Inc. | 33.79 Million USD | -1261.19% |
Clever Leaves Holdings Inc. | 31.24 Million USD | -1372.41% |
Cyclo Therapeutics, Inc. | 13.24 Million USD | -3372.532% |
Avadel Pharmaceuticals plc | 261.12 Million USD | -76.17% |
Hempacco Co., Inc. | 18.04 Million USD | -2449.592% |
Talphera, Inc. | 20.39 Million USD | -2155.577% |
Alvotech | 950.09 Million USD | 51.581% |
Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -13.262% |
Lantheus Holdings, Inc. | 1.65 Billion USD | 72.139% |
Currenc Group, Inc. | 141.49 Million USD | -225.128% |
Kamada Ltd. | 351.96 Million USD | -30.7% |
Indivior PLC | 1.95 Billion USD | 76.424% |
Evoke Pharma, Inc. | 7.06 Million USD | -6408.057% |
Flora Growth Corp. | 23.62 Million USD | -1847.113% |
Cyclo Therapeutics, Inc. | 13.24 Million USD | -3372.532% |
Evolus, Inc. | 188.99 Million USD | -143.402% |
HUTCHMED (China) Limited | 1.27 Billion USD | 64.054% |
Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 69.593% |
Akanda Corp. | 8.83 Million USD | -5103.907% |